skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: assunto: Tumors remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

IMHOF, Anna ; BRUNNER, Philippe ; MARINCEK, Nicolas ; BRIEL, Matthias ; SCHINDLER, Christian ; RASCH, Helmut ; MÄCKE, Helmut R ; ROCHLITZ, Christoph ; MÜLLER-BRAND, Jan ; WALTER, Martin A

Journal of clinical oncology, 2011-06, Vol.29 (17), p.2416-2423 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers

VILLARD, Linda ; ROMER, Anna ; BRIEL, Matthias ; WALTER, Martin A ; MARINCEK, Nicolas ; BRUNNER, Philippe ; KOLLER, Michael T ; SCHINDLER, Christian ; NG, Quinn KT ; MÄCKE, Helmut R ; MÜLLER-BRAND, Jan ; ROCHLITZ, Christoph

Journal of clinical oncology, 2012-04, Vol.30 (10), p.1100-1106 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study

Marincek, Nicolas ; Jörg, Ann-Catherine ; Brunner, Philippe ; Schindler, Christian ; Koller, Michael T ; Rochlitz, Christoph ; Müller-Brand, Jan ; Maecke, Helmut R ; Briel, Matthias ; Walter, Martin A

Journal of translational medicine, 2013-01, Vol.11 (1), p.17-17, Article 17 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

Rochlitz, C. ; Ruhstaller, T. ; Lerch, S. ; Spirig, C. ; Huober, J. ; Suter, T. ; Bühlmann, M. ; Fehr, M. ; Schönenberger, A. ; von Moos, R. ; Winterhalder, R. ; Rauch, D. ; Müller, A. ; Mannhart-Harms, M. ; Herrmann, R. ; Cliffe, B. ; Mayer, M. ; Zaman, K.

Annals of oncology, 2011-01, Vol.22 (1), p.80-85 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Toxic Encephalopathy Induced by Capecitabine
Toxic Encephalopathy Induced by Capecitabine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Toxic Encephalopathy Induced by Capecitabine

Niemann, B. ; Rochlitz, C. ; Herrmann, R. ; Pless, M.

Oncology, 2004-01, Vol.66 (4), p.331-335 [Periódico revisado por pares]

Basel, Switzerland: Karger

Texto completo disponível

Citações Citado por
6
[90Yttrium-DOTA]-TOC Response Is Associated With Survival Benefit in Iodine-Refractory Thyroid Cancer : Long-term Results of a Phase 2 Clinical Trial
[90Yttrium-DOTA]-TOC Response Is Associated With Survival Benefit in Iodine-Refractory Thyroid Cancer : Long-term Results of a Phase 2 Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

[90Yttrium-DOTA]-TOC Response Is Associated With Survival Benefit in Iodine-Refractory Thyroid Cancer : Long-term Results of a Phase 2 Clinical Trial

ITEN, Fabienne ; MULLER, Beat ; SCHINDLER, Christian ; RASCH, Helmut ; ROCHLITZ, Christoph ; OERTLI, Daniel ; MAECKE, Helmut R ; MULLER-BRAND, Jan ; WALTER, Martin A

Cancer, 2009-05, Vol.115 (10), p.2052-2062 [Periódico revisado por pares]

Hoboken, NJ: Wiley-Blackwell

Texto completo disponível

Citações Citado por
7
SMAD7 is a prognostic marker in patients with colorectal cancer
SMAD7 is a prognostic marker in patients with colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

SMAD7 is a prognostic marker in patients with colorectal cancer

Boulay, Jean‐Louis ; Mild, Gabriele ; Lowy, Adam ; Reuter, Juergen ; Lagrange, Magali ; Terracciano, Luigi ; Laffer, Urban ; Herrmann, Richard ; Rochlitz, Christoph

International journal of cancer, 2003-04, Vol.104 (4), p.446-449 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
8
Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian Cancer
Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian Cancer

Salzberg, Marc ; Thürlimann, Beat ; Bonnefois, Hervé ; Fink, Daniel ; Rochlitz, Christoph ; von Moos, Roger ; Senn, Hansjörg

Oncology, 2005-01, Vol.68 (4-6), p.293-298 [Periódico revisado por pares]

Basel, Switzerland: Karger

Texto completo disponível

Citações Citado por
9
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

RIBI, K ; ALDRIDGE, J ; PRICE, K. N ; GELBER, R. D ; BERNHARD, J ; PHILLIPS, K.-A ; THOMPSON, A ; HARVEY, V ; THÜRLIMANN, B ; CARDOSO, F ; PAGANI, O ; COATES, A. S ; GOLDHIRSCH, A

British journal of cancer, 2012-05, Vol.106 (10), p.1618-1625 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Regan, M.M. ; Pagani, O. ; Walley, B. ; Torrisi, R. ; Perez, E.A. ; Francis, P. ; Fleming, G.F. ; Price, K.N. ; Thürlimann, B. ; Maibach, R. ; Castiglione-Gertsch, M. ; Coates, A.S. ; Goldhirsch, A. ; Gelber, R.D.

Annals of oncology, 2008-07, Vol.19 (7), p.1231-1241 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1997  (3)
  2. 1997Até1999  (4)
  3. 2000Até2004  (6)
  4. 2005Até2011  (7)
  5. Após 2011  (3)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.